Literature DB >> 6989989

James Mackenzie Lecture 1979. The happiness pill?

C R Kay.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 6989989      PMCID： PMC2159386     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN： 0035-8797


× No keyword cloud information.
  20 in total

1.  Effects of certain 19-nor steroids on the normal human menstrual cycle.

Authors:  C R GARCIA; G PINCUS; J ROCK
Journal:  Science       Date:  1956-11-02       Impact factor: 47.728

2.  Effects of certain 19-nor steroids on reproductive processes in animals.

Authors:  G PINCUS; M C CHANG; E S HAFEZ; M X ZARROW; A MERRILL
Journal:  Science       Date:  1956-11-02       Impact factor: 47.728

3.  10-NOR-PROGESTERONE, A PHYSIOLOGICALLY ACTIVE LOWER HOMOLOG OF PROGESTERONE.

Authors:  W M Allen; M Ehrenstein
Journal:  Science       Date:  1944-09-15       Impact factor: 47.728

4.  Serum-lipids in women on oral contraceptives.

Authors:  T Stokes; V Wynn
Journal:  Lancet       Date:  1971-09-25       Impact factor: 79.321

5.  Formulation-dependent effect of oral contraceptives on H.D.L.-cholesterol.

Authors:  J D Shelton; D Petitti
Journal:  Lancet       Date:  1978-09-23       Impact factor: 79.321

6.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

7.  Mortality in women on oral contraceptives.

Authors: 
Journal:  Lancet       Date:  1977-10-08       Impact factor: 79.321

8.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

9.  Mortality among women participating in the Oxford/Family Planning Association contraceptive study.

Authors:  M P Vessey; K McPherson; B Johnson
Journal:  Lancet       Date:  1977-10-08       Impact factor: 79.321

10.  Reduced high-density lipoprotein in women aged 40-41 using oral contraceptives. Consultation Bureau Heart Project.

Authors:  A C Arntzenius; C M van Gent; H van der Voort; C I Stegerhoek; K Styblo
Journal:  Lancet       Date:  1978-06-10       Impact factor: 79.321
View more
  8 in total

Review 1.  History of the Royal College of General Practitioners--the first 40 years.

Authors:  D P Gray
Journal:  Br J Gen Pract       Date:  1992-01       Impact factor: 5.386

2.  The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women.

Authors:  S G Thompson; T W Meade; G Greenberg
Journal:  J Epidemiol Community Health       Date:  1989-06       Impact factor: 3.710

3.  Problem patients and the 'pill'.

Authors:  F M Graham
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

4.  Blood pressure and contraceptive use.

Authors:  C R Kay
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11

5.  Interaction of ethinyloestradiol with ascorbic acid.

Authors:  C Kay
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-20

6.  Incidence of arterial disease among oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study.

Authors: 
Journal:  J R Coll Gen Pract       Date:  1983-02

Review 7.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

8.  Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium.

Authors:  G Lane; N C Siddle; T A Ryder; J Pryse-Davies; R J King; M I Whitehead
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.